指南&解读指南

订阅

MedSci主页 / 所有栏目 / 指南&解读指南

沙库巴曲缬沙坦钠片生物等效性研究技术指导原则

2021-08-17 国家药品监督管理局药品审评中心（CDE） CDE

生物等效性

沙库巴曲缬沙坦钠片生物等效性研究技术指导原则

中文标题：

沙库巴曲缬沙坦钠片生物等效性研究技术指导原则

发布机构：

国家药品监督管理局药品审评中心（CDE）

发布日期：

2021-08-17

简要介绍：

沙库巴曲缬沙坦钠片生物等效性研究技术指导原则

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7a9e71c00216093d, title=沙库巴曲缬沙坦钠片生物等效性研究技术指导原则, enTitle=, guiderFrom=CDE, authorId=0, author=, summary=沙库巴曲缬沙坦钠片生物等效性研究技术指导原则, cover=, journalId=0, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心（CDE）, associationIntro=国家药品监督管理局药品审评中心（CDE）, copyright=0, guiderPublishedTime=Tue Aug 17 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">沙库巴曲缬沙坦钠片生物等效性研究技术指导原则</span></p>, tagList=[TagDto(tagId=53297, tagName=生物等效性)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1408, appHits=51, showAppHits=0, pcHits=475, showPcHits=1356, likes=0, shares=7, comments=5, approvalStatus=1, publishedTime=Tue Aug 24 13:29:12 CST 2021, publishedTimeString=2021-08-17, pcVisible=1, appVisible=1, editorId=4754896, editor=小小医者, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=小小医者, createdTime=Mon Aug 23 17:39:40 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 01:27:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1012620, encodeId=10211012620ee, content=很好的文章 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sun Aug 29 19:06:10 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011111, encodeId=5caa1011111f0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9db35583959, createdName=李欣睿, createdTime=Tue Aug 24 20:34:28 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010988, encodeId=6730101098808, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/a9f050ba6fd24b748a621de87dc6d332/06311ac2af5041eb90ab47d2fb7f5f22.jpg, createdBy=3ed95422947, createdName=医生小邵, createdTime=Tue Aug 24 15:37:43 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-08-29 karlxun

    很好的文章

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1012620, encodeId=10211012620ee, content=很好的文章 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sun Aug 29 19:06:10 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011111, encodeId=5caa1011111f0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9db35583959, createdName=李欣睿, createdTime=Tue Aug 24 20:34:28 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010988, encodeId=6730101098808, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/a9f050ba6fd24b748a621de87dc6d332/06311ac2af5041eb90ab47d2fb7f5f22.jpg, createdBy=3ed95422947, createdName=医生小邵, createdTime=Tue Aug 24 15:37:43 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-08-24 李欣睿

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1012620, encodeId=10211012620ee, content=很好的文章 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sun Aug 29 19:06:10 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011111, encodeId=5caa1011111f0, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9db35583959, createdName=李欣睿, createdTime=Tue Aug 24 20:34:28 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010988, encodeId=6730101098808, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/a9f050ba6fd24b748a621de87dc6d332/06311ac2af5041eb90ab47d2fb7f5f22.jpg, createdBy=3ed95422947, createdName=医生小邵, createdTime=Tue Aug 24 15:37:43 CST 2021, time=2021-08-24, status=1, ipAttribution=)]
    2021-08-24 医生小邵

    学习

    0

相关指南

碳酸镧咀嚼片生物等效性研究技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2021-08-04

维格列汀片生物等效性研究技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2021-08-03

窄治疗指数药物生物等效性研究技术指导原则（2020年）

国家药品监督管理局药品审评中心（CDE） · 2020-12-31